Biofrontera Inc. (BFRI)
NASDAQ: BFRI · Real-Time Price · USD
0.8400
+0.0449 (5.65%)
Apr 24, 2025, 4:00 PM EDT - Market closed
Biofrontera Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Biofrontera stock has a target of 7.00, which predicts an increase of 733.33% from the current stock price of 0.84.
Analyst Consensus: Strong Buy
* Price targets were last updated on Nov 15, 2024.
Analyst Ratings
According to 1 stock analyst, the rating for Biofrontera is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Benchmark | Benchmark | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +733.33% | Nov 15, 2024 |
| Benchmark | Benchmark | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +733.33% | Aug 16, 2024 |
| Benchmark | Benchmark | Strong Buy Reiterates $18 | Strong Buy | Reiterates | $18 | +2,042.86% | Aug 31, 2023 |
| Benchmark | Benchmark | Strong Buy Maintains $140 → $18 | Strong Buy | Maintains | $140 → $18 | +2,042.86% | Jul 5, 2023 |
| Benchmark | Benchmark | Strong Buy Reiterates $140 | Strong Buy | Reiterates | $140 | +16,566.67% | May 15, 2023 |
Financial Forecast
Revenue This Year
44.25M
from 37.32M
Increased by 18.57%
Revenue Next Year
53.18M
from 44.25M
Increased by 20.17%
EPS This Year
-0.83
from -3.22
EPS Next Year
0.08
from -0.83
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 45.9M | 57.0M | 75.0M | ||
| Avg | 44.3M | 53.2M | 72.9M | ||
| Low | 42.2M | 49.0M | 70.0M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 22.9% | 28.8% | 41.1% | ||
| Avg | 18.6% | 20.2% | 37.0% | ||
| Low | 13.2% | 10.7% | 31.7% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -0.49 | 0.08 | 0.36 |
| Avg | -0.83 | 0.08 | 0.35 |
| Low | -1.13 | 0.08 | 0.33 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | 337.5% |
| Avg | - | - | 325.0% |
| Low | - | - | 308.3% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.